Mct-150 1.5ml Microcentrifuge Tube with Cap Mct-150

Name: Mct-150 1.5ml Microcentrifuge Tube with Cap Mct-150
Brand: Hangzhou A-Gen Biotechnology Co., Ltd.
SKU: 1964927795

Zhejiang, ChinaHangzhou A-Gen Biotechnology Co., Ltd.

Negotiable

1 Box

Sample price:US$0.00/bag.Request sample

Product profile

Customization

Available

Certification

CE, ISO, RoHS

Material

Rubber / Plastic

Model NO.

MCT-150

Capacity

1.5mL

Application

Laboratory

Transport Package

Carton

Specification

500pcs/pack 10pack/case

Trademark

A-gen

Origin

China

HS Code

3926909090

Production Capacity

500000PC/Month

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceYears of Export ExperienceExperienced Team

Hangzhou A-Gen Biotechnology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 15 years CertifiedNearest Port: Shanghai Port; Ningbo PortAverage Response Time: ≤1.81h

AI-Powered supplier vetting

SummaryThe supplier operates in analytical instruments, plastic products, plastic-processing equipment, molds, and certain medical devices. It demonstrates broad customization capability, approximately 15 years of export experience, self-operated import and export rights, overseas agents or branches, and participation in Medlab Asia. Quality and service processes are documented, with complaint handling, traceability, warehouse controls, supplier-management procedures, and corrective-action records. The supplier has 14 quality-control staff and two R&D engineers, but reports no quality-control testing equipment and no SDK availability. It provides OEM services for well-known brands and has one national science and technology progress award. Financial information is limited to year labels rather than assessable metrics, while no cooperation with Fortune 500 companies, overseas warehouse, or overseas showroom is reported.

Supplier typeThe supplier is a manufacturer and seller covering analytical instruments, plastic products, plastic-processing equipment, molds, and selected medical devices. Its scope includes plastic-product manufacturing and analytical instruments, indicating a diversified industrial and equipment-oriented supplier profile.

After-Sales capabilityThe supplier has documented complaint-handling procedures and records, corrective and preventive-action procedures, supplier-service assessment procedures, and warehouse controls. It offers overseas-agent or branch support and has participated in Medlab Asia, but has no overseas warehouse or showroom and reports zero overseas service countries, so its service reach is only partially demonstrated.

R&D capabilityThe supplier reports one national science and technology progress award, two R&D engineers, customer-oriented new-product development responsibilities, and new products launched in the last year. However, it has no available SDK, so the evidence supports product-development activity but not SDK-based integration capability.

Production capacityThe supplier reports plastic-product manufacturing, broad product sales and equipment scope, standardized finished-product inspection instructions, warehouse quality procedures, 14 quality-control staff, and raw-material traceability. A stated quantity of zero for quality-control test equipment is a significant production-quality limitation, although the records do not establish the full extent of its impact.

Customization capabilityThe supplier explicitly offers flexible, minor, full, design-based, and sample-based customization. Its two R&D engineers are responsible for developing and designing products according to customer requirements, directly supporting tailored product development.

Client casesThe supplier provides OEM services for well-known brands, has approximately 15 years of export experience, participates in offline trade shows such as Medlab Asia, and reports a repeat-buyer proportion of 50%–80%. However, it reports no cooperation with Fortune 500 companies and provides no named customer references, so the strength of its customer case portfolio is only partially verifiable.